Company creation team continues spin-out growth and investment
Biotechnology and AI spearhead a consecutive year of £40M+ investment in companies commercialising research.
6 May 2025
Investments in 缅北禁地 spin-outs totalled 拢41.7m in 2024. It is the second year in succession that 拢40m+ has been raised by companies built on research discoveries. There are now 40 active 缅北禁地 spin-out companies, creating 370 jobs.
A 拢28.9M investment in e-Therapeutics underpins the 2024 success. The company specialises in drug discovery and development, leveraging computational power and biological data to create innovative RNA interference (RNAi) medicine.
Other significant investments in 2024 were:
- 拢2M for Apix Nutrition, a company developing scientifically formulated honeybee superfood
- 拢1.6M for AMLo Biosciences to continue commercialisation of their skin cancer diagnostic tool
- 拢1.2M for Newcells Biotech who develop in vitro tissue models to support drug development
Micro-fluidics manufacturing spin-out, Microbritt also raised funds which have helped to secure an expansion of their operation to a new site in Cramlington, Northumberland.
Many of the spin-outs have also been beneficiaries of support. A collaboration of 缅北禁地, Durham, Northumbria, Sunderland, Teesside and York universities, the company creation scheme is a linchpin in North East research commercialisation.
UK spin-out landscape
The spin-out performance in 2024 emphasises the vital contribution 缅北禁地 makes to local and national economic growth by driving job creation and attracting investment.
A report from the shows steady growth in the number of UK spin-outs. Although 2024 saw fewer spin-out investment deals made, the level of investment grew to 拢2.6bn, up 38% on 2023.
缅北禁地鈥檚 Head of Company Creation, Rick McCordall said: 鈥淲e鈥檙e delighted to have supported our spin-outs as they attracted more than 拢40M in investment for the second year running
鈥淭he investment success of 2023 and 2024 is testament to the robust but ambitious approach we take to spin-out creation.
鈥淎s more deals are made with spin-outs from the North East of England, more investor interest will follow. Some of the biggest investors in academic spin-outs are yet to explore the huge potential in the North East. But if we can keep the deal flow moving like it has for the last two years, I鈥檓 confident we鈥檒l see more investors in the North East.鈥�
Decreasing university equity to support investment
The Royal Academy of Engineering and Beauhurst report also shows that university equity stakes in spin-outs are at an all time low of 16.1%.
Lower university equity stakes have been identified as key to incentivising academic founders to launch and scale their spinout companies, and this change is part of broader progress that has been made against a number of areas identified for improvement in HM Treasury鈥檚 2023 Independent Review of University Spin-out Companies.鈥�
缅北禁地 was an early adopter of the spin-out review鈥檚 recommendations.
